about
Identifying and managing performance concerns in community pharmacists in the UK.Existing arrangements for monitoring community pharmacies in England: can they have a role in the revalidation of pharmacists?Managing workplace stress in community pharmacy organisations: lessons from a review of the wider stress management and prevention literature.Workplace stress in community pharmacies in England: associations with individual, organizational and job characteristics.Revalidation arrangements for pharmacy professionals in industry and academia in Great Britain: a qualitative study.Organisational and extraorganisational determinants of volume of service delivery by English community pharmacies: a cross-sectional survey and secondary data analysis.The relationships among work stress, strain and self-reported errors in UK community pharmacy.Patient and public perspectives of community pharmacies in the United Kingdom: A systematic review.Care managers' time use: differences between community mental health and older people's services in the United Kingdom.How do organisational configuration and context influence the quantity and quality of NHS services provided by English community pharmacies? A qualitative investigationAssessing the impact of care management in the community: associations between key organisational components and service outcomesAn exploration of the utility of appraisals for the revalidation of pharmacy professionals in community pharmacy in Great BritainSolidarity or dissonance? A systematic review of pharmacist and GP views on community pharmacy services in the UKApplying a whole systems lens to the general practice crisis: cross-sectional survey looking at usage of community pharmacy services in England by patients with long-term respiratory conditionsSupporting patients with long-term conditions in the community: Evaluation of the Greater Manchester Community Pharmacy Care Plan Service
P50
Q38408684-73D180B8-2A37-437C-9A06-EB27D446C3E1Q38409533-A08CBF29-15DA-4E91-98A5-FC300054AA47Q38871730-A2454416-9301-44C0-ABB8-7E0120723323Q39353982-A4767E8C-BD0B-404A-9CB6-E70EE7DBFDF8Q39447365-D07F6888-6E24-45EC-BD95-0FEDC1E3D973Q42650106-D4561FE7-EE9E-4105-9854-02B1C09082ECQ45781892-A508E059-B0D4-4BFB-8957-575AB1418F53Q47635441-56860190-5524-4B83-937B-F957EBF6CD47Q51908541-0EC4BFB3-96A9-4B21-A138-31A254D30237Q58712943-D1FA03D3-FDD0-4672-A228-53E94B9D55FBQ80043838-4C61EF1A-01BE-4369-BE72-67E92011346FQ86446683-7DDD817B-68D7-438C-B845-70DF80663ECDQ90486558-45C3D15C-31EC-4766-85FE-D7DB3822CA24Q91172229-13E59B17-34B3-4D82-B004-494CA4269479Q91889051-3D491EA6-0E13-492B-BC38-4A0B6919B2F6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sally Jacobs
@ast
Sally Jacobs
@en
Sally Jacobs
@es
Sally Jacobs
@nl
type
label
Sally Jacobs
@ast
Sally Jacobs
@en
Sally Jacobs
@es
Sally Jacobs
@nl
prefLabel
Sally Jacobs
@ast
Sally Jacobs
@en
Sally Jacobs
@es
Sally Jacobs
@nl
P106
P1153
7402313290
P31
P496
0000-0002-6199-5748